Medicare Part D coverage · ergotamine tartrate · RxCUI 1293864
ergotamine tartrate 2 MG Sublingual Tablet [Ergomar]
Per the CMS 2026 Part D formulary file, ergotamine tartrate 2 MG Sublingual Tablet [Ergomar] is covered by 215 Medicare Part D plans (4.3% of enrollable products), averaging Tier 3.7, with prior authorization required on 0% of covering formularies.
- 4.3%
- Plan coverage
- 215
- Plans covering
- T3.7
- Avg tier
- 0%
- Prior auth required
What the CMS Formulary Data Shows for ergotamine tartrate 2 MG Sublingual Tablet [Ergomar]
Per the CMS 2026 Part D formulary file, ergotamine tartrate 2 MG Sublingual Tablet [Ergomar] (RxNorm concept RXCUI 1293864, generic name ergotamine tartrate) appears on 9 distinct formulary files spanning 215 Medicare Part D plan offerings - 4.3% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 3.7.
Real-world access to ergotamine tartrate 2 MG Sublingual Tablet [Ergomar] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 33.3% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 15 Part D beneficiaries filled ergotamine tartrate 2 MG Sublingual Tablet [Ergomar] in 2023, with total plan-and-beneficiary spending of $41,477 and an average per-beneficiary annual cost of $2,765.10. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry ergotamine tartrate 2 MG Sublingual Tablet [Ergomar] today.
Coverage Details
- Formularies covering
- 9
- Plans covering
- 215
- Coverage rate
- 4.3%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 33.3% of formularies
2023 Medicare Spending
- Beneficiaries
- 15
- Total spending
- $41,477
- Avg per beneficiary
- $2,765.10
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering ergotamine tartrate 2 MG Sublingual Tablet [Ergomar]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| NaviCare (HMO D-SNP) | Fallon Community Health Plan | T1 | No | $0 | MA |
| SCAN Connections (HMO D-SNP) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN Connections at Home (HMO D-SNP) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN Classic (HMO) | Scan Health Plan Nevada, Inc. | T3 | No | $0 | NV |
| SCAN Balance (HMO C-SNP) | Scan Health Plan Nevada, Inc. | T3 | No | $0 | NV |
| SCAN Strive (HMO C-SNP) | Scan Health Plan Nevada, Inc. | T3 | No | $0 | NV |
| SCAN MyChoice (HMO) | Scan Health Plan Nevada, Inc. | T3 | No | $0 | NV |
| SCAN Classic (HMO) | Scan Desert Health Plan, Inc. | T3 | No | $0 | AZ |
| SCAN Balance (HMO C-SNP) | Scan Desert Health Plan, Inc. | T3 | No | $0 | AZ |
| SCAN Embrace (HMO-POS I-SNP) | Scan Desert Health Plan, Inc. | T3 | No | $0 | AZ |
| SCAN Strive (HMO C-SNP) | Scan Desert Health Plan, Inc. | T3 | No | $0 | AZ |
| SCAN MyChoice (HMO) | Scan Desert Health Plan, Inc. | T3 | No | $0 | AZ |
| SCAN Classic WA (HMO) | Scan Health Plan (WA) | T3 | No | $0 | WA |
| SCAN MyChoice WA (HMO) | Scan Health Plan (WA) | T3 | No | $0 | WA |
| SCAN Classic (HMO) | Scan Health Plan (NM) | T3 | No | $0 | NM |
| SCAN Balance (HMO C-SNP) | Scan Health Plan (NM) | T3 | No | $0 | NM |
| SCAN Strive (HMO C-SNP) | Scan Health Plan (NM) | T3 | No | $0 | NM |
| SCAN MyChoice (HMO) | Scan Health Plan (NM) | T3 | No | $0 | NM |
| SCAN Classic (HMO) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN Classic (HMO) | Scan Health Plan | T3 | No | $0 | CA |
Show the next 30 plans
| SCAN Classic (HMO) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN Classic (HMO) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN Classic (HMO) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN Classic (HMO) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN Classic (HMO) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN Balance (HMO C-SNP) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN Prime (HMO) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN Classic (HMO) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN Balance (HMO C-SNP) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN Classic (HMO) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN Balance (HMO C-SNP) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN Alta (HMO) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN Venture (HMO) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN Venture (HMO) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN Embrace (HMO I-SNP) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN Embrace (HMO I-SNP) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN Embrace (HMO-POS I-SNP) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN Affirm partnered with Included LGBTQ+ Health (HMO) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN Affirm partnered with Included LGBTQ+ Health (HMO) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN Strive (HMO C-SNP) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN Strive (HMO C-SNP) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN Inspired by women for women (HMO) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN Classic (HMO) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN Balance (HMO C-SNP) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN Balance (HMO C-SNP) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN Balance (HMO C-SNP) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN Balance (HMO C-SNP) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN Affirm partnered with Included LGBTQ+ Health (HMO) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN MyChoice (HMO) | Scan Health Plan | T3 | No | $0 | CA |
| SCAN MyChoice (HMO) | Scan Health Plan | T3 | No | $0 | CA |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is ergotamine tartrate 2 MG Sublingual Tablet [Ergomar] covered by Medicare Part D?
Yes, ergotamine tartrate 2 MG Sublingual Tablet [Ergomar] is covered by 215 Medicare Part D plans (4.3% of all Part D formularies).
What tier is ergotamine tartrate 2 MG Sublingual Tablet [Ergomar] on Medicare Part D plans?
ergotamine tartrate 2 MG Sublingual Tablet [Ergomar] averages Tier 3.7 across Part D plans, ranging from Tier 1 to Tier 5.
Does ergotamine tartrate 2 MG Sublingual Tablet [Ergomar] require prior authorization?
0% of Part D formularies require prior authorization for ergotamine tartrate 2 MG Sublingual Tablet [Ergomar]. Step therapy: 0%. Quantity limits: 33.3%.
How much does Medicare spend on ergotamine tartrate 2 MG Sublingual Tablet [Ergomar]?
In 2023, total Medicare Part D spending on ergotamine tartrate 2 MG Sublingual Tablet [Ergomar] was $41,477, covering 15 beneficiaries. The average spend per beneficiary was $2,765.10.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.